Exome Asset Management LLC 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Exome Asset Management LLC disclosed 53 US equity positions worth $202.4m in its Q4 2025 13F filing. The largest position was PRAX at 8.5% of the reported book, followed by COGT and GH. Against the Q3 2025 filing, it opened 19 new positions, added to 5 and reduced 15 among the top 50 holdings.
What did Exome Asset Management LLC own in Q4 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 8.5% | $17.1m | 58,122 | -43% | reduced |
| 2 | COGT COGENT BIOSCIENCES INC | Healthcare | 5.4% | $10.9m | 305,568 | -31% | reduced |
| 3 | GH GUARDANT HEALTH INC | Healthcare | 5.0% | $10.0m | 98,182 | 0% | held |
| 4 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 4.6% | $9.2m | 116,515 | -11% | reduced |
| 5 | LLY ELI LILLY & CO | Healthcare | 4.2% | $8.4m | 7,852 | 0% | held |
| 6 | CYTK CYTOKINETICS INC | Healthcare | 3.9% | $7.9m | 124,749 | -12% | reduced |
| 7 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 3.5% | $7.2m | 421,488 | – | new |
| 8 | VERA VERA THERAPEUTICS INC | Healthcare | 3.1% | $6.3m | 124,391 | -20% | reduced |
| 9 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.1% | $6.2m | 80,723 | -39% | reduced |
| 10 | ELV ELEVANCE HEALTH INC FORMERLY | Healthcare | 3.0% | $6.0m | 17,191 | – | new |
| 11 | AZN ASTRAZENECA PLC | Healthcare | 2.6% | $5.3m | 28,362 | 0% | held |
| 12 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 2.2% | $4.5m | 26,494 | – | new |
| 13 | NTRA NATERA INC | Healthcare | 2.1% | $4.3m | 18,650 | 0% | held |
| 14 | IMVT IMMUNOVANT INC | Healthcare | 2.0% | $4.0m | 158,622 | 0% | held |
| 15 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 1.9% | $3.8m | 17,628 | 122% | added |
| 16 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.8% | $3.7m | 7,685 | 16% | added |
| 17 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.8% | $3.7m | 136,942 | – | new |
| 18 | IRON DISC MEDICINE INC | Healthcare | 1.8% | $3.7m | 46,743 | -24% | reduced |
| 19 | ISRG INTUITIVE SURGICAL INC | Healthcare | 1.8% | $3.6m | 6,358 | 0% | held |
| 20 | GKOS GLAUKOS CORP | Healthcare | 1.8% | $3.6m | 31,471 | 16% | added |
| 21 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 1.7% | $3.4m | 222,308 | – | new |
| 22 | CELC CELCUITY INC | Healthcare | 1.7% | $3.4m | 34,289 | – | new |
| 23 | APLSUSD APELLIS PHARMACEUTICALS INC | 1.7% | $3.4m | 135,849 | – | new | |
| 24 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.7% | $3.4m | 89,052 | -43% | reduced |
| 25 | DXCM DEXCOM INC | Healthcare | 1.6% | $3.3m | 50,147 | – | new |
| 26 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.6% | $3.3m | 49,758 | -52% | reduced |
| 27 | CTMX CYTOMX THERAPEUTICS INC | Healthcare | 1.6% | $3.2m | 745,305 | 0% | held |
| 28 | LQDA LIQUIDIA CORPORATION | Healthcare | 1.6% | $3.1m | 91,148 | -3% | reduced |
| 29 | VSTM VERASTEM INC | Healthcare | 1.5% | $3.1m | 401,743 | – | new |
| 30 | ALMS ALUMIS INC | 1.4% | $2.9m | 292,250 | -0% | held | |
| 31 | PEN PENUMBRA INC | Healthcare | 1.4% | $2.8m | 9,000 | 0% | held |
| 32 | TXG 10X GENOMICS INC | Healthcare | 1.3% | $2.7m | 163,658 | 0% | held |
| 33 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 1.3% | $2.7m | 76,750 | – | new |
| 34 | EWTX EDGEWISE THERAPEUTICS INC | 1.2% | $2.5m | 100,046 | -42% | reduced | |
| 35 | NXTC NEXTCURE INC | 1.2% | $2.3m | 165,000 | – | new | |
| 36 | BLTE BELITE BIO INC | Healthcare | 1.1% | $2.3m | 14,328 | – | new |
| 37 | WAY WAYSTAR HLDG CORP | Healthcare | 1.1% | $2.3m | 68,969 | 47% | added |
| 38 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 1.1% | $2.2m | 648,532 | – | new |
| 39 | KPTI KARYOPHARM THERAPEUTICS INC | 1.1% | $2.2m | 295,541 | – | new | |
| 40 | ADAG ADAGENE INC | 1.0% | $2.0m | 1,060,221 | – | new | |
| 41 | NBP NOVABRIDGE BIOSCIENCES | Healthcare | 1.0% | $2.0m | 499,587 | -65% | reduced |
| 42 | UNH UNITEDHEALTH GROUP INC | Healthcare | 1.0% | $1.9m | 5,835 | – | new |
| 43 | PALI PALISADE BIO INC | Healthcare | 0.9% | $1.8m | 758,203 | – | new |
| 44 | UPB UPSTREAM BIO INC | 0.9% | $1.8m | 64,845 | 25% | added | |
| 45 | GOSS GOSSAMER BIO INC | Healthcare | 0.7% | $1.4m | 451,699 | 0% | held |
| 46 | IKT INHIBIKASE THERAPEUTICS INC | 0.6% | $1.2m | 600,000 | – | new | |
| 47 | IQV IQVIA HLDGS INC | Healthcare | 0.6% | $1.2m | 5,378 | – | new |
| 48 | THC TENET HEALTHCARE CORP | Healthcare | 0.6% | $1.2m | 6,084 | -66% | reduced |
| 49 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 0.6% | $1.1m | 139,543 | -39% | reduced |
| 50 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.5% | $1.0m | 92,055 | -7% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.